Deciding whether a GLP-1 agonist is on the table
Who decides about a GLP-1 agonist
That is a decision for you and a prescriber, made with the label and the official pages below in hand. Bring the questions in the next steps to that conversation.
Where to look
Start with the label for any GLP-1 medication you are offered. The FDA announcement of a medication for chronic weight management and the NIDDK page on prescription medications for overweight and obesity are useful starting points. For one example of a label-style drug page, see MedlinePlus on semaglutide injection. Also read the published concerns about unapproved GLP-1 drugs used for weight loss, and check the source of any product.
Busy weeks
If you start one, ask ahead of time what to do about a missed dose, a trip, or a change in your schedule.
Preparing for the GLP-1 conversation
- Read the label directions.
- Write down your goals and your health history.
- Ask your prescriber whether a GLP-1 agonist is relevant to you.
- Ask how follow-up works.
Why labels cannot say if you need one
Labels and official pages are the starting point on when a GLP-1 agonist is used, and they do not decide whether you need one. Your prescriber decides what fits.